Pune, India, July 14, 2021 (GLOBE NEWSWIRE) — The worldwide non-opioid ache therapy market valued at USD 13,200.6 million in 2020, and it’s projected to develop at a CAGR of 16.8 % through the forecast interval. Non-opioid analgesics are prescribed and over-the-counter (OTC) drugs is used to ease the ache. They’ve change into step by step emphasised in varied scientific settings as a most popular, efficient, and protected first-line remedy substitute to opioid drugs for power ache and gentle to reasonable acute ache.
Get Pattern Copy of This Report @ https://www.quincemarketinsights.com/request-sample-69826
Non-opioid ache therapy includes sturdy ache relievers. This therapy is finished within the place of opioids resulting from elevated dependancy brought on by opioids. They’ve extra negative effects examine to non-opioids medicine. Non-opioid medicine are used as a first-line of therapy for acute ache. They’re current in prescribed formulations and over-the-counter remedy to ease ache. With the opioid disaster and minimize down on the prescription of opioid painkillers, non-opioids painkillers are the substitute to opioid painkiller. That is anticipated to propel the non-opioids ache therapy market progress.
Growing prevalence of power illness will additional propel the non-opioids ache therapy market progress. Growing spending on analysis and improvement, present process scientific trials, and alter within the governing setting will enhance the help for a number of non-opioid medicine which set off the expansion of the non-opioids ache therapy market. Modernized improvement pathway for non-opioid analgesics and partnership among the many main producers for the drug improvement is predicted to spice up the non-opioids ache therapy market.
Rising prevalence of ailments, similar to most cancers, arthritis, dental problems, and epilepsy, resulting in power ache circumstances, similar to migraine, osteoarthritis, decrease again ache, fibromyalgia, localized neuropathic ache, and localized musculoskeletal ache, are driving the worldwide non-opioid ache therapy market progress.
Elements such because the excessive value of patent medicine and the usage of opioids in quite a few underneath creating and developed nations will restrain the non-opioid ache therapy market within the forecast interval.
World Non-Opioid Ache Therapy Market, by Product
Based mostly on product, the non-opioid ache therapy market is segmented into medical hashish therapies, capsaicin-derived therapies, menthol-containing therapies, omega-3 fatty acid-containing therapies, and botulinum toxins.
Amongst all product segments of non-opioid ache therapy, the medical hashish therapies phase has the quickest market progress in 2021 and is predicted to carry its place through the forecast interval. The phase progress may be attributed to the growing burden of ailments, which is predicted to drives the demand for the medical hashish therapy phase through the forecast interval.
Moreover, the growing aged inhabitants which generates excessive demand for healthcare companies, and the excessive demand for hashish for medical use as a result of authorized use of medical hashish in developed nations are anticipated to drive the phase progress through the forecast interval.
World Non-Opioid Ache Therapy Market, by Illness
Based mostly on illness, the non-opioid ache therapy market is segmented into arthritis, most cancers, dental, epilepsy, fibromyalgia, migraine, a number of sclerosis, and surgical. The most cancers phase is additional divided into mind, breast, colorectal, leukemia/lymphoma, melanoma, prostate, and others.
The most cancers phase has the quickest market progress cumulatively in 2021 and is anticipated to stay the quickest phase till the forecast interval 2030. The expansion of most cancers phase is attributed to non-opioid ache therapy for most cancers sufferers usually current with power ache, which boosts the expansion of non-opioid ache therapy market progress within the forecast interval.
As well as, rising consciousness relating to the negative effects related to most cancers therapy like hair loss is anticipated to drive the demand for non-opioid ache therapy within the forecast interval.
World Non-Opioid Ache Therapy Market, by Drug Sort
Based mostly on drug sort, the non-opioid ache therapy market is segmented into acetaminophen, non-steroidal anti-inflammatory medicine, corticosteroids, anticonvulsants, and serotonin-norepinephrine reuptake inhibitor antidepressants. The corticosteroids phase holds the biggest phase in 2021 and is projected to stay the biggest phase through the forecast interval.
Corticosteroids have been proven to lower spontaneous discharge in an injured nerve, which reduces neuropathic ache, which is predicted to contribute to phase progress through the forecast interval. As well as, corticosteroids are additionally used to deal with despair, which might increase the market progress through the forecast interval.
Purchase Now Full Report @ https://www.quincemarketinsights.com/insight/buy-now/non-opioid-pain-treatment-market/single_user_license
World Non-Opioid Ache Therapy Market, by Distribution Channel
Based mostly on the distribution channel, the non-opioid ache therapy market is segmented into hospital pharmacies, retail pharmacies, drug shops, and on-line pharmacies. The hospital pharmacies phase holds the biggest market share in 2021 and is predicted to stay the biggest market through the forecast interval.
The expansion of the hospital pharmacies phase may be attributed to numerous technological developments leading to larger success charges post-treatment and surgical procedures, and the supply of environment friendly affected person care, which is considerably contributing to the hospital pharmacies phase progress through the forecast interval.
World Non-Opioid Ache Therapy Market, by Area:
Based mostly on area, the non-opioid ache therapy market is segmented into North America, Europe, Asia Pacific, Center East and Africa, and South America. The non-opioid ache therapy market in North America is anticipated to carry the biggest share through the forecast interval owing to favorable regulatory state of affairs.
The important thing issue contributing to the North American market is the growing prevalence of osteoarthritis within the inhabitants. The extended entry to medical care due to healthcare reforms additional propels the regional market. Due to this fact, the economies on this area and rising demographics are predictable to supply good alternatives for regional market progress.
Asia Pacific market is predicted to be the fastest-growing area for the non-opioid ache therapy market. The vast majority of the market is generated in much less established nations with relaxed rules relating to hashish. Japan, China, and India are the highest markets for these medicine owing to the excessive demand for higher well being administration and consciousness about ache remedy, and financial circumstances. As well as, the rising aged inhabitants on this area will even have an effect on the market positively.
Some Current Developments within the World Non-opioid Ache Therapy Market:
- June 2019- Ironwood Prescribed drugs and Allergan began affected person dosing in Section II Scientific Trial of MD-7246 in sufferers with belly ache associated with irritable bowel syndrome with diarrhea (IBS-D). The businesses are evaluating the product, as an oral, intestinal, non-opioid, pain-relieving agent for sufferers affected by belly ache related to sure GI ailments.
- June 2018- Sandoz Canada declared partnership settlement with Tilray, a Well being Canada licensed producer of medical hashish to change into the primary Canadian pharmaceutical firm to come back into the medical hashish subject
- January 2018- Centrexion Therapeutics raised USS 67 million and launched Section 3 program for CNTX-4975 in knee osteoarthritis ache. CNTX-4975, ultra-pure, an artificial injection of trans-capsaicin for the therapy of power ache owing to knee osteoarthritis. CNTX-4975 is a novel, extremely differentiated, non-opioid remedy designed to be inserted instantly into the painful joint.
COVID-19 Influence on World Non-opioid Ache Therapy Market
The QMI crew is intently observing the impression of COVID-19 on the non-opioid ache therapy market. The nationwide lockdown and steady enhance in an infection charges throughout the nation generated a widespread monetary impression on the clinic’s companies. The massive variety of ache and clinic companies has noticed a drop in a number of affected person visits amid COVID-19 in the end dropping consumer contact. Thus, a adverse impression of COVID-19 on the non-opioid ache therapy market is noticed.
Some Main Findings of the World Non-opioid Ache Therapy Market Embrace:
- Main international market development and forecasts evaluation together with a country-specific market evaluation for as much as 25 nations
- An in-depth international non-opioid ache therapy market evaluation by the aforementioned segments, together with an evaluation of trend-based insights and components
- Profiles of main market gamers working within the international non-opioid ache therapy market, which embody Pfizer Inc., Eli Lilly and Firm, Teva Pharmaceutical Industries Ltd., Regeneron Prescribed drugs, Centrexion Therapeutics, Novartis AG, US WorldMeds, LLC, GW Prescribed drugs plc. Cara Therapeutics, Anodyne Ache, LLC, and Trait Biosciences
- Aggressive benchmarking, product providing particulars, progress methods adopted by the main market gamers, together with their main investments within the final 5 years
- Key impression issue evaluation throughout areas that embody evaluation, together with the drivers, restraints, alternatives, and challenges which might be prevailing within the international market
- Influence of COVID-19 on the worldwide non-opioid ache therapy market
Browse key business insights unfold throughout 165 pages with 85 market knowledge tables and 41 figures & charts from the report, “Non-Opioid Pain Treatment Market, by Product (Medical Hashish Therapies, Capsaicin-derived Therapies, Menthol-containing Therapies, Omega-3 Fatty Acid-Containing Therapies, and Botulinum Toxins), Illness (Arthritis, Most cancers, Dental, Epilepsy, Fibromyalgia, Migraine, A number of Sclerosis, Surgical), Drug Sort (Acetaminophen, Non-Steroidal Anti-Inflammatory Medicine, Corticosteroids, Anticonvulsants, Serotonin Norepinephrine Reuptake Inhibitor Antidepressants), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Shops, On-line Pharmacies), and Area (North America, Europe, Asia Pacific, Center East and Africa, South America) — Market Dimension and Forecasting to 2030” in-depth evaluation together with the desk of contents (ToC).
Enquiry Earlier than Shopping for This Report @ https://www.quincemarketinsights.com/enquiry-before-buying/enquiry-before-buying-69826
Quince Market Insights
Cellphone: US +1 208 405 2835
UK +44 1444 39 0986
APAC +91 706 672 4848
Browse Associated Stories:
Non-Opioid Ache Patches Market, By Sort (Lidocaine Patches, Diclofenac Patches, Methyl Salicylate Patches, Capsaicin Patches, Ketoprofen Patches, and Others), By Distribution Channel (Hospitals Pharmacies, On-line Pharmacies, Drug Shops, and Others), By Area (North America, Japanese Europe, Western Europe, Asia Pacific, Center East, Remainder of the World) – Market Dimension & Forecasting (2016-2028)
Hashish Testing Providers Market, By Check Sort (Efficiency Testing, Terpene Profiling, Cannabinoid Profiling, Pesticide Screening, Residual Solvent Testing, Microbiological Screening), Finish Consumer (Hashish Companies, Homecare Settings, Analysis Institutes) ,and By Area (North America, Western Europe, Japanese Europe, Asia Pacific, Center East, and the Remainder of the World) – Market Dimension & Forecasting (2017-2028).
World Authorized Hashish Market, By Compound (THC-Dominant, CBD-Dominant, Balanced THC, and CBD), By Software (Medical, Leisure), By Sort (Flowers, Concentrates), By Area (North America, South America, Europe, and Remainder of the World) – Market Dimension & Forecasting (2016-2028)
Topical Ache Reduction Market, By Therapeutic Class (Non-Opioids, Opioids), By Sort (Prescription Ache Reduction, Over-the-Counter Ache Reduction), By Formulation (Cream, Gel, Spray, Patch, Others), By Distribution Channel (Pharmacies & Drug Shops, e-Commerce, Retail & Grocery Shops), By Area (North America, Western Europe, Japanese Europe, Asia Pacific, Center East, Remainder of the World) – Market Dimension & Forecasting (2016-2028)
Opioids Market, By Product (Codeine, Fentanyl, Methadone, Oxycodone, Morphine, Hydrocodone, Others), By Software (Ache Administration, Cough Therapy, Diarrhea), By Area (North America, Japanese Europe, Western Europe, Asia Pacific, Center East, Remainder of the World) – Market Dimension & Forecasting (2016-2028)